Effects of High Volume Hemofiltration on Acute Kidney Injury in Patients with Cardiotomy
TAO Jing,JI Daxi,GONG Dehua,XU Bing,LIU Zhihong,LI Leishi
DOI: https://doi.org/10.3969/j.issn.1006-298x.2007.03.009
2007-01-01
Abstract:Objective:To evaluate the efficiency of high volume hemofiltration (HVHF) in the treatment of acute kidney injury(AKI)in patients with cardiotomy, and investigate the impact of therapy on prognosis in the different stage of AKI. Methodology:HVHF was performed in 25 patients with AKI after cardiotomy, including 16 males and 9 females, with average age of 15~80(56.4±16.80) years. Except 6 of the patients quitted in early stage of HVHF for economics, the remaining 19 patients were divided into three groups. They were group Ⅰ ( AKI Ⅰ stage,n=6) received HVHF when SCr was ≥0.3 mg/dl (≥26.4 μmol/L) or increased to ≥150%-200% (1.5-to 2-fold) from baseline, or0.5 ml/(kg·h) for6 hours, group Ⅱ (AKI Ⅱ stage,n=6), HVHF was started when SCr200%-300%(2-to 3-fold) from baseline, or0.5 ml/(kg·h) for12 hours, and group Ⅲ (AKI Ⅲ,n=7) had HVHF when SCr300%(3-fold) from baseline (SCr≥4.0 mg/dl (≥354 μmo/L) with an acute increase of at least 0.5 mg/dl(44 μmol/L), or0.5 ml/(kg·h) for12 hours. HVHF was performed with AV600 hemofilter (polysulfone, 1.6 m2). The rate of substitute fluid was at 4 000 ml/h by a pre-dilution route, and the rate of blood flow was 200-250 ml/min. Low molecular weight heparin and/or citrate were used for anticoagulation. The general conditions of each patients including blood pressure (BP), heart rate (HR), and temperature (T) were monitored every 30 minutes, and the blood gas analysis, serum biochemistry test were detected before and every 24 hours after the initiation of HVHF. APACHEⅡscores were evaluated every 12 hours during HVHF. Results:HVHF was well tolerated in all patients and the hospital mortality of 57.9%. The mortality of group I was lower than group III(50% vs 71.4%)while the patients in group I were more severe: the cardiopulmonary bypass(CPB)time[(244.2±170.46) vs (154.3±73.58)]and x-clamp time[(93.2±43.21) vs (82±59.59)]were both longer than group III,and more patients accepted IABP (66.7% vs 28.6%). After 12 hours' HVHF treatment, the high fever of patients was improved obviously(P0.05), while heart rate and MAP was maintained in normal range. After 24 hours' therapy, the serum creatinine and blood urea were both decreased (P0.05), and all survival patients had renal function recovered. After HVHF (60 hrs), we also found APACHE II scores improved significantly (P0.05). Conclusion:HVHF is technically possible in AKI patients after cardiotomy, which was an important treatment to post-cardiac operation patients with AKI and MODS. We also found that early HVHF performed in AKI I stage was better, which had lower mortality.